MicroRNAs: Promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential

doi:10.3748/wjg.v20.i38.13658

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 38

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7433)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

510

WORD

273

HTML

3789

Figures (1-1)

184

Tables (1-2)

140

Sum=4896

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1304

Download

1233

Sum=2537

Oct 14, 2014 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (22)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Topic Highlight

World J Gastroenterol. Oct 14, 2014; 20(38): 13658-13666
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13658

Open in New Tab Full Size Figure Download Figure

Figure 1 MicroRNAs and their influence on multidrug resistance in gastric cancer. The figure presents an overview about the targets and pathways that mediate the effects of miRNA manipulation on multidrug resistance in gastric cancer (Data modified from DIANA miRPathv2.0[90]). The arrows indicate the up- or down-regulation of miRNA patterns in gastric cancer cells in vitro. The dashed boxes indicate nucleus related targets. Interrogation marks represent to date unknown intermediate steps. STAT: Signal transducers and activators of transcription; mTOR: Mammalian target of rapamycin; PKB: Protein kinase B.

Citation: Matuszcak C, Haier J, Hummel R, Lindner K. MicroRNAs: Promising chemoresistance biomarkers in gastric cancer with diagnostic and therapeutic potential. World J Gastroenterol 2014; 20(38): 13658-13666
URL: https://www.wjgnet.com/1007-9327/full/v20/i38/13658.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i38.13658